Verona Pharma gains as preliminary 4Q sales exceed estimates
-- Verona Pharma (NASDAQ:VRNA), the pharmaceutical company known for its pulmonary disease drug, Ohtuvayre, has reported a premarket gain of 4.6% after the company...
-- Verona Pharma (NASDAQ:VRNA), the pharmaceutical company known for its pulmonary disease drug, Ohtuvayre, has reported a premarket gain of 4.6% after the company...
FRANKFURT (Reuters) - Mercedes-Benz (OTC:MBGAF) will lower mid-term profitability targets for its passenger car business due to prolonged weakness in the market and the switch to...
UBS strategists expressed caution regarding China's equity market, citing a challenging start to 2025. Local A-share investors are reportedly reluctant to engage in buying...
VCI Global Limited (VCIG) (“VCI Global,” or the “Company”), today announced the carve-out of its wholly owned subsidiary, V Capital Consulting Group Limited (“VCCG”), for listing...
-- Shares of Acadia Healthcare Company Inc (NASDAQ:ACHC) rose in pre-market trading Tuesday following an upgrade by KeyBanc Capital Markets, which raised the...
-- Barclays adjusted its restaurant sector ratings, upgrading Shake Shack Inc (NYSE:SHAK) and Dutch Bros to ‘overweight,’ while downgrading Bloomin’ Brands and Dine...
-- Buy-rated Roku (NASDAQ:ROKU) has been named the top stock pick for 2025 by analysts at Needham & Company, who see multiple drivers for significant growth in the...
- Serve Robotics shares dropped over 14% in premarket trading following the announcement of a registered direct offering. The company disclosed agreements with...
By Krystal Hu (Reuters) - Artificial intelligence startups have contributed significantly to the recovery of U.S. venture capital funding from market lows, with the total capital...
-- Morgan Stanley (NYSE:MS) has revised its ratings on several European oil and gas companies, reflecting a mixed outlook for the sector in 2025. Analysts raised...